USANA amends $75M credit facility, sets $100M minimum EBITDA covenant and allows Sydney property sale

USANA HEALTH SCIENCES INC

USANA entered a First Amendment to its June 27, 2025 credit agreement on Sept. 30, 2026, with Bank of America as administrative agent.
The $75,000,000 revolving facility matures June 27, 2030 and may be increased by up to $200,000,000 upon request.
Minimum Consolidated EBITDA covenant is $100,000,000 for trailing four quarters, dropping to $70,000,000 if aggregate revolving exposure is $50,000,000 or less.
Annual general asset sale basket rises from $500,000 to $2,500,000; new clause permits USANA Australia Pty, Ltd to sell Sydney real property.
Sale-leaseback transactions remain prohibited except as agreed by Required Lenders or if tied to the Sydney disposition.

This headline and bullets were generated automatically by deepseek-v4.1-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.